Advancing Ethical, predictive in vitro science
Our rigorous science and customized study designs accelerate safer products to market while supporting ethical innovation worldwide.
Our certified expertise powers customized testing strategies that generate high-quality, non-clinical data de-risking innovation while bridging scientific challenges and regulatory compliance.
Timeline
2001
Incorporation
VitroScreen was founded pioneering in vitro science’s revolution in life science
2010
GLP certification
VitroScreen holds since 2010, the Good Laboratory Practice (GLP) certification, ensuring compliance with internationally recognized quality and reliability standards.
2014
EU-NETVAL
Since 2014, VitroScreen has been a member of the Network of European Union Laboratories for the Validation of Alternative Methods.
2021
Acquisition
VitroScreen is acquired by SenzaGen Group. SenzaGen is listed on Nasdaq Stockholm (SENZA).
2023
ISO Certifications
VitroScreen achieves UNI EN ISO 9001 and UNI CEI EN ISO 13485 certified status, confirming the robustness of its quality management system and compliance with international standards for medical device-related activities.
VitroScreen together with Tox-Hub is part of the SenzaGen Group, a leader in innovative in vitro testing solutions.
Harnessing SenzaGen Group synergy, while maintaining full operational and scientific autonomy we fuse VitroScreen’s advanced in vitro platforms, SenzaGen’s genomic GARD®testing expertise, and ToxHub’s élite toxicology consulting to reinforce our position as a trusted, internationally recognized provider of cutting-edge non-animal testing.
Sustainability driven by advanced human-relevant science
VitroScreen advances a science-driven sustainability vision, grounded in the ethical imperative and superior predictive reliability of non-animal alternative methods. Through the development and application of sophisticated 3D in vitromodels—including reconstructed human tissues, cellular spheroids—we significantly reduce reliance on animal testing. This approach enables precise, reproducible, and responsible safety and efficacy assessments across Cosmetics, Medical devices, Nutraceuticals, Pharma and Chemicals industries.